RARECast
Podcast autorstwa RARECast - Czwartki
548 Odcinki
-
Deriving Rare Disease Therapies from Human Plasma
Opublikowany: 18.10.2017 -
Learning to Live with Purpose
Opublikowany: 11.10.2017 -
A Mother's Race to Find a Treatment for Her Daughter's Ultra-Rare Condition
Opublikowany: 4.10.2017 -
Screening for Rare Diseases
Opublikowany: 27.09.2017 -
A Look at the Changing World of Work for People with a Chronic Illness
Opublikowany: 20.09.2017 -
Aligning Interests in Rare Disease Partnerships
Opublikowany: 13.09.2017 -
A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development
Opublikowany: 6.09.2017 -
A Patient Group Crafts Guidelines for Working with Pharma
Opublikowany: 30.08.2017 -
Bringing Innovation to Business Models for Rare Disease Drug Development
Opublikowany: 23.08.2017 -
Rethinking Accessibility and Dependency
Opublikowany: 16.08.2017 -
How Simon Wheatcroft, Blinded by a Rare Disease, Became an Ultramarathoner
Opublikowany: 9.08.2017 -
Spark Hoping Its Luxturna Will Become First FDA-Approved Gene Therapy
Opublikowany: 2.08.2017 -
What Rare Patient-Investors Can Learn From Venture Capitalists
Opublikowany: 26.07.2017 -
Novel Effort Delivers Failed DMD Drug to Former Clinical Trial Participants
Opublikowany: 19.07.2017 -
Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early
Opublikowany: 12.07.2017 -
Albireo Advances Pipeline for Rare Liver and Gastrointestinal Diseases
Opublikowany: 5.07.2017 -
aTyr Pharma Seeks to Modulate Activity in FSHD and Other Rare Disease
Opublikowany: 28.06.2017 -
Summit Pursues A Different Approach to Treating Duchenne
Opublikowany: 21.06.2017 -
Delivering Enzyme Replacement Therapies Across the Blood-Brain Barrier
Opublikowany: 14.06.2017 -
Sangamo Advances Gene Editing Therapies for Multiple Rare Diseases into the Clinic
Opublikowany: 7.06.2017
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.